To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia

• Status: Completed
• Trial end date: 2009-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zeria Pharmaceutical
• Treatments: Z 338

Criteria

Inclusion Criteria:

• Subjects presenting diagnosis of FD as defined by the Rome II

• Subjects presenting postprandial fullness and/or Early satiety should be the most bothersome symptom

Exclusion Criteria:

-